Human IL-6 Protein, premium grade

  • GMP version GMP-L06H27 is now available for seamless transition.
Customer Reviews
Cat. No. / Size
Price
Qty
Premium grade lyophilized
IL6-H4218-20ug
$190.00
IL6-H4218-50ug
$345.00
IL6-H4218-1mg (100ug X 10)
$2610.00
GMP lyophilized
GMP-L06H27-50ug
$470.00
GMP-L06H27-1mg (50ug X 20)
$4080.00
GMP-L06H27-10mg (50ug X 200)
$28560.00
ETA of in-stock products:2 business days

Product Details

  • Features and Advantages

    1. Seamless Transition from Preclinical to Clinical: Same cell clone, process, and QC as GMP products.
    2. Enhanced Production Standards: AOF raw materials, pharma-grade excipients, Grade B+A (ISO 5) environment.
    3. Comprehensive Quality Control: Additional strict testing for process impurities, sterility, and mycoplasma.
    4. Cost-Effective Solution: GMP-comparable quality at an economical price for early development.
    5. Risk Mitigation: Enhanced safety through rigorous impurity control and comprehensive testing.
  • Synonyms

    IL6, Interleukin-6, BSF2, HSF, IFNB2

  • Source

    Human IL-6, premium grade (IL6-H4218) is expressed from human 293 cells (HEK293). It contains AA Val 30 - Met 212 (Accession # P05231).

    Predicted N-terminus: Val 30

    It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage.
    GMP-L06H27 is the GMP version of this IL6-H4218. These two proteins display indistinguishable performance profiles, thereby ensuring a seamless transition for end users from early preclinical stage to later clinical phases.

    Request for sequence
  • Molecular Characterization

    IL-6 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries no "tag".

    The protein has a calculated MW of 20.8 kDa. The protein migrates as 23-29 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Host Cell Protein

    <0.5 ng/µg of protein tested by ELISA.

  • Host Cell DNA

    <0.02 ng/μg of protein tested by qPCR.

  • Sterility

    Negative

  • Mycoplasma

    Negative

  • Purity

    >95% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process
  • Quality Description

    ACRO's Research-grade products are suitable for a wide range of cell culture applications, particularly for research use in academic institutions. These products are sterilized by filtration, followed by lyophilization where applicable. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. Biological activity is calibrated against WHO/NIBSC standards when available.
    ACRO's Premium-grade (Pre-GMP) products are characterized by their high quality and enhanced safety profiles, making them ideal for early-stage discovery and manufacturing processes in cell therapy companies. A key advantage is their seamless transition to corresponding GMP-grade versions. Biological activity is calibrated against WHO/NIBSC standards when available. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. In addition, rigorous testing is conducted to ensure the absence of mycoplasma, HCD, and HCP, thereby guaranteeing product safety.

Customers Also Viewed

Performance Data

  • SDS-PAGE

    IL-6 SDS-PAGE

    Human IL-6, premium grade on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • Bioactivity-CELL BASE

     IL-6 CELL

    Human IL-6, premium grade (Cat. No. IL6-H4218) stimulates proliferation of TF-1 human erythroleukemic cell line. The specific activity of Human IL-6, premium grade is > 1.00×10^8 IU/mg, which is calibrated against human IL-6 WHO International Standard (NIBSC code: 21/308) (QC tested).

    Protocol
  •  IL-6 CELL

    The activity of Human IL-6 Protein, premium grade (Cat. No. IL6-H4218) was higher than other competing products.

    Protocol
  • Bioactivity-Stability

     IL-6 STABILITY

    Cell-based assay demonstrates batch-to-batch consistency between Acro's GMP and PG IL-6.

Customer Reviews
Writing Reviews

Background

Interleukin 6 (IL-6) is also known as HGF, BSF2,HSF, IFNB2 and IL-6, originally identified as a B cell differentiation factor, is a multifunctional cytokine that regulates immune responses, hematopoiesis, acute phase responses, and inflammatory reactions.It is secreted by T cells, macrophages , monocytes, fibroblasts,endothelial cells,et.al. to stimulate immune response to trauma, especially burns or other tissue damage leading to inflammation. Interleukin 6 has been shown to interact with interleukin-6 receptor and glycoprotein. IL-6 is relevant to many disease processes such as diabetes,atherosclerosis, depression,Alzheimer's Disease,systemic,lupus erythematosus,prostate cancer and rheumatoid arthritis. Advanced/metastatic cancer patients have higher levels of IL-6 in their blood.Hence there is an interest in developing anti-IL-6 agents as therapy against many of these diseases.

Recent Advances

 
Drug Development Progress
  • English Name:

    Interleukin-6

  • Category:

  • Approved Drugs:

    5 Details

  • Drugs in Clinical Trials:

    22 Details

  • Highest Development Stage:

    Approved

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background